Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.660
-0.030 (-1.78%)
At close: Sep 25, 2026, 4:00 PM EDT
1.612
-0.048 (-2.91%)
After-hours: Sep 25, 2026, 7:51 PM EDT
Bionano Genomics Employees
As of December 31, 2025, Bionano Genomics had 97 total employees, including 95 full-time and 2 part-time employees. The number of employees decreased by 3 or -3.00% compared to the previous year.
Employees
97
Change (1Y)
-3
Growth (1Y)
-3.00%
Revenue / Employee
$311,093
Profits / Employee
-$331,577
Market Cap
19.55M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 97 | -3 | -3.00% | 95 | 2 |
| Dec 31, 2024 | 100 | -244 | -70.93% | 98 | 2 |
| Dec 31, 2023 | 344 | -61 | -15.06% | 344 | 0 |
| Sep 30, 2023 | 388 | -17 | -4.20% | 388 | 0 |
| Dec 31, 2022 | 405 | 106 | 35.45% | 405 | 0 |
| Dec 31, 2021 | 299 | 152 | 103.40% | 299 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Retractable Technologies | 201 |
| Stereotaxis | 131 |
| Precision Optics Corporation | 90 |
| Femasys | 54 |
| Nephros | 36 |
| Milestone Scientific | 15 |
| Lucyd | 13 |
BNGO News
- 3 days ago - Bionano Laboratories Announces Expansion of Diagnostic Testing Based on Optical Genome Mapping for Hematologic Malignancies - GlobeNewsWire
- 12 days ago - Bionano Genomics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 12 days ago - Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia - GlobeNewsWire
- 16 days ago - Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms - GlobeNewsWire
- 18 days ago - Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping - GlobeNewsWire
- 4 weeks ago - Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - Bionano Genomics Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Bionano Genomics Earnings release: Q2 2026 - Filings